BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12447687)

  • 1. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
    Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
    Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism.
    Sciacca L; Costantino A; Pandini G; Mineo R; Frasca F; Scalia P; Sbraccia P; Goldfine ID; Vigneri R; Belfiore A
    Oncogene; 1999 Apr; 18(15):2471-9. PubMed ID: 10229198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
    Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
    Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D
    Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of IGF-I and insulin receptor isoforms in HPV positive and negative human cervical cancer cell lines.
    Serrano ML; Sánchez-Gómez M; Bravo MM; Yakar S; LeRoith D
    Horm Metab Res; 2008 Oct; 40(10):661-7. PubMed ID: 18711691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis.
    Singleton JR; Randolph AE; Feldman EL
    Cancer Res; 1996 Oct; 56(19):4522-9. PubMed ID: 8813151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-II regulates metastatic properties of choriocarcinoma cells through the activation of the insulin receptor.
    Diaz LE; Chuan YC; Lewitt M; Fernandez-Perez L; Carrasco-Rodríguez S; Sanchez-Gomez M; Flores-Morales A
    Mol Hum Reprod; 2007 Aug; 13(8):567-76. PubMed ID: 17556377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II.
    Kuo WW; Liu CJ; Chen LM; Wu CH; Chu CH; Liu JY; Lu MC; Lin JA; Lee SD; Huang CY
    Apoptosis; 2006 Jul; 11(7):1075-89. PubMed ID: 16699953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors.
    Chen H; Yan GC; Gishizky ML
    Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
    Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells.
    Zhang G; Li X; Zhang L; Zhao L; Jiang J; Wang J; Wei L
    Cancer Genet Cytogenet; 2010 Jul; 200(2):140-8. PubMed ID: 20620597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
    Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A
    Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
    Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
    Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
    Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
    J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factors induce apoptosis as well as proliferation in LIM 1215 colon cancer cells.
    Fu P; Thompson JA; Leeding KS; Bach LA
    J Cell Biochem; 2007 Jan; 100(1):58-68. PubMed ID: 16888814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin binding.
    Pandini G; Conte E; Medico E; Sciacca L; Vigneri R; Belfiore A
    Ann N Y Acad Sci; 2004 Dec; 1028():450-6. PubMed ID: 15650270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor receptor I targeting in epithelial ovarian cancer.
    Gotlieb WH; Bruchim I; Gu J; Shi Y; Camirand A; Blouin MJ; Zhao Y; Pollak MN
    Gynecol Oncol; 2006 Feb; 100(2):389-96. PubMed ID: 16300820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
    Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL
    Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.